CEPI Commits $4.17m to Study Vaccine Protection Against Ebola Virus

CEPI commits $4.17m to study vaccine protection against Ebola virus

The research comes as the Democratic Republic of the Congo (DRC) continues to battle the outbreak caused by Bundibugyo ebolavirus. The post CEPI commits $4.17m to study vaccine protection against Ebola virus appeared first on Premium Times Nigeria.

CEPI funds studies on Ebola vaccine protection against Bundibugyo virus

Researchers will analyse immune responses in previously vaccinated people to determine whether existing Ebola vaccines could offer protection against the related virus.

UofG’s CVR contributes to Ebola health emergency

The MRC-University of Glasgow Centre for Virus Research (CVR) will play a key role in new studies to assess whether vaccines already or previously licensed against Zaire ebolavirus—including Ervebo—could offer protection against Bundibugyo ebolavirus, the virus behind the rapidly escalating outbreak in the Democratic Republic of the Congo, which was declared a Public Health Emergency of International Concern by the World Health Organization (WHO…

CEPI funds $4.17m studies to test Ebola vaccines against Bundibugyo virus

The virus is responsible for the escalating outbreak in the Democratic Republic of the Congo (DRC), which the World Health Organization (WHO) declared a public health emergency of international concern in May.